South Africa: Interim clinical guidance for the implementation of injectable-free regimens

The document provides interim clinical guidance on implementation of the modified short and long treatment regimens for people with rifampicin-resistant TB (RR-TB) in South Africa following the release of the WHO Rapid Communication: Key changes to treatment of multidrug- and rifampicin-resistant tuberculosis (MDR/RR-TB).

National guidelines will be revised in 2019 following publication of the updated WHO policy guidelines on MDR-TB treatment (expected later in 2018).

To subscribe to the Weekly Newsletter of new posts, enter your email here:

By Republic of South Africa Department of Health

Published: Oct. 17, 2018, 11:39 a.m.

Last updated: Oct. 17, 2018, 11:43 a.m.

Print Share